Back to Top
Antibody Drug Conjugate
-
Ado-Trastuzumab Emtansine Biosimilar - Research Grade$1,250.00 - $19,500.00 -
-
Trastuzumab Deruxtecan Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Girentuximab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Tusamitamab Ravtansine Biosimilar - Research Grade$1,050.00 - $4,536.00
-
-
Zolbetuximab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
Rovalpituzumab Vedotin Biosimilar - Research Grade$700.00 - $3,024.00
-
-
Who Bought This Also Bought
